SGS is pleased to return to CPhI Frankfurt 2025, where its experts will share insights on analytical testing in ADC development and demonstrate the company’s end-to-end drug development support services.
GENEVA – SGS, the world’s leading testing, inspection and certification company, will attend CPhI Frankfurt 2025, taking place October 28–30 at Messe Frankfurt, Germany. This flagship event gathers pharmaceutical professionals worldwide to explore the latest trends and innovations in drug development, manufacturing and supply chain management.
At stand 5.0A102 in the Contract Manufacturing and Services zone, attendees can meet SGS experts and learn how the company’s comprehensive portfolio helps accelerate the development of efficacious, safe and compliant medicines.
Key capabilities include a global network of GMP/GLP laboratories providing testing, formulation and clinical support services for pharma, biopharma and medical devices.
SGS experts Luc-Alain Savoy and Philippe Grimm will also deliver a presentation entitled ‘Analytical Testing in ADC Development: From Cell Bank Characterization to Market Approval’ on October 29, 2025, 13:45–14:10 CEST, at the Next-Gen Bio Theatre, Hall 4.1J48. Attendees will gain in-depth insights into ensuring quality, safety and consistency across all antibody-drug conjugate (ADC) production intermediates.
CPhI Frankfurt 2025 is an essential event for pharmaceutical and biotech professionals seeking integrated, end-to-end solutions that accelerate drug development while meeting global regulatory expectations.
Register now to attend CPhI Frankfurt 2025 (https://www.cphi.com/europe/en/attend/attend/pricing-opti…)
Book a meeting (https://try.sgs.com/en/book-a-meeting-cphi-frankfurt/?utm…) with SGS’s expert team
For further information, please contact:
Daisy Coleman
Global Marketing Manager – Pharma
Tel: (+33) 614292765
About SGS
SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of 99,500 dedicated professionals. With over 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.
Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and trusted specialized brands, including Brightsight, Bluesign, Maine Pointe and Nutrasource.
SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN:SW).
